JPH0469995B2 - - Google Patents
Info
- Publication number
- JPH0469995B2 JPH0469995B2 JP58176772A JP17677283A JPH0469995B2 JP H0469995 B2 JPH0469995 B2 JP H0469995B2 JP 58176772 A JP58176772 A JP 58176772A JP 17677283 A JP17677283 A JP 17677283A JP H0469995 B2 JPH0469995 B2 JP H0469995B2
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- afp
- hybridoma
- membrane
- plc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000004027 cell Anatomy 0.000 claims description 33
- 210000004408 hybridoma Anatomy 0.000 claims description 25
- 102100023635 Alpha-fetoprotein Human genes 0.000 claims description 22
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 6
- 201000000050 myeloid neoplasm Diseases 0.000 claims description 6
- 108010026331 alpha-Fetoproteins Proteins 0.000 claims description 4
- 210000004989 spleen cell Anatomy 0.000 claims description 4
- 230000007910 cell fusion Effects 0.000 claims description 3
- 239000012528 membrane Substances 0.000 description 18
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- 208000014018 liver neoplasm Diseases 0.000 description 9
- 239000012228 culture supernatant Substances 0.000 description 8
- 201000007270 liver cancer Diseases 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 210000002826 placenta Anatomy 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000000539 two dimensional gel electrophoresis Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 235000011330 Armoracia rusticana Nutrition 0.000 description 2
- 240000003291 Armoracia rusticana Species 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- 101000848653 Homo sapiens Tripartite motif-containing protein 26 Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 102000046101 human AFP Human genes 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 102000013415 peroxidase activity proteins Human genes 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- 230000007928 solubilization Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58176772A JPS6066979A (ja) | 1983-09-24 | 1983-09-24 | ハイブリド−マ |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58176772A JPS6066979A (ja) | 1983-09-24 | 1983-09-24 | ハイブリド−マ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6066979A JPS6066979A (ja) | 1985-04-17 |
| JPH0469995B2 true JPH0469995B2 (ko) | 1992-11-09 |
Family
ID=16019555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58176772A Granted JPS6066979A (ja) | 1983-09-24 | 1983-09-24 | ハイブリド−マ |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6066979A (ko) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2635267B1 (fr) * | 1988-08-09 | 1992-05-22 | Tokuyama Soda Kk | Anticorps monoclonaux et procede pour les produire |
-
1983
- 1983-09-24 JP JP58176772A patent/JPS6066979A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6066979A (ja) | 1985-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hauri et al. | Monoclonal antibodies to sucrase/isomaltase: probes for the study of postnatal development and biogenesis of the intestinal microvillus membrane. | |
| US4446122A (en) | Purified human prostate antigen | |
| JP2761012B2 (ja) | 組換ｄｎａ産物及び方法 | |
| USRE33405E (en) | Purified human prostate antigen | |
| EP0252769A2 (en) | Anti-human pulmonary carcinoma monoclonal antibody | |
| US5639656A (en) | Antibodies reactive with biological markers of benign prostate hyperplasia | |
| US5130415A (en) | Synthetic peptide endowed with immunological activity, capable of inducing the production of antibodies with a high specificity towards alpha-fetoprotein, and their use in the diagnostic field | |
| IE870487L (en) | Lung carcinoma antigen and antibody | |
| US4957859A (en) | Antibodies for transforming ras protein | |
| JP2567564B2 (ja) | ヒト非小細胞肺癌に関する抗原 | |
| Xu et al. | Development of two new monoclonal antibodies reactive to a surface antigen present on human ovarian epithelial cancer cells | |
| JPH0742320B2 (ja) | 転移性ヒト腫瘍を確認する方法および組成物 | |
| AU702294B2 (en) | Proteins from mammalian liver and their use in oncology | |
| EP0369816A2 (en) | Monoclonal antibodies specific for human polymorphic epithelial mucin | |
| JP2898293B2 (ja) | エンドセリンに対する抗体およびその用途 | |
| CA1165685A (en) | Purified prostatic tissue antigen | |
| JP2831852B2 (ja) | ヒト胸腺皮質細胞上に発現する細胞表面タンパク質及びその利用 | |
| JPH0469998B2 (ko) | ||
| JPH02154694A (ja) | 肺癌モノクローナル抗体および細胞表面抗原 | |
| AU670247B2 (en) | Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof | |
| US5200316A (en) | Immunoassay methods using noncross reactive cea gene family members antibodies | |
| EP0594879A1 (en) | Cathepsin L-specific monoclonal antibodies, hybridomas for producing the same and a method of using the same | |
| JPH0469995B2 (ko) | ||
| US5032521A (en) | Monoclonal antibody specific for a mammary tumor cell surface antigen | |
| Mather et al. | Preparation of monoclonal antibodies to xanthine oxidase and other proteins of bovine milk-fat-globule membrane. |